CSPC Pharmaceutical Group Limited (CSPCY)

Market Cap	11.04B +36.9%
Revenue (ttm)	3.69B -5.9%
Net Income	473.21M -22.2%
EPS	0.04 -20.6%
Shares Out	n/a
PE Ratio	23.34
Forward PE	11.14
Dividend	0.10 (2.62%)
Ex-Dividend Date	Oct 20, 2025

Volume	n/a
Open	3.790
Previous Close	3.750
Day's Range	3.790 - 3.790
52-Week Range	3.450 - 5.830
Beta	0.80
Analysts	n/a
Price Target	n/a
Earnings Date	May 27, 2026

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma,...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1992
• Employees: 19,700
• Stock Exchange: OTCMKTS
• Ticker Symbol: CSPCY

Financial Performance

In 2025, CSPC Pharmaceutical Group's revenue was 26.01 billion, a decrease of -10.35% compared to the previous year's 29.01 billion. Earnings were 3.88 billion, a decrease of -10.30%.

Financial numbers in CNY